The Newest At-Home COVID-19 Test Is A Game Changer
The very first non-prescription at-home COVID-19 test has been approved by the U.S. Food and Drug Administration, The Washington Post …
Two thirds of people with lupus would take COVID-19 vaccine, survey shows
Two out of three people with lupus (64%) are willing to take a COVID-19 vaccine if it is free and …
One in four people globally may not get Covid-19 vaccines until 2022
Nearly one in four people may not get Covid-19 vaccines until at least 2022 because rich countries with less than …
Distributing Our COVID-19 Vaccine to the World
MRNA VS. CONVENTIONAL VACCINES Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron Working Together to Empower Women Pfizer Women’s …
Newly diagnosed cancer patients, especially African Americans, more at risk for COVID-19 infection
Cancer patients, especially newly diagnosed and African American patients, are significantly at risk for COVID-19 infection, hospitalization and mortality, according …
FDA Approves Emergency Use of Pfizer’s COVID-19 Vaccine
SATURDAY, Dec. 12, 2020 – The U.S. Food and Drug Administration approved Pfizer’s coronavirus vaccine for emergency use on Friday, …
Latest study could help future therapies to sway Covid-19 virus
Study published in the journal cell online revealed that by targeting a single protein cell which appears essential for SARS-CoV-2 …
BNT162b2 Vaccine 95 Percent Effective for Preventing COVID-19
FRIDAY, Dec. 11, 2020 — A two-dose regimen of a lipid nanoparticle-formulated, nucleoside-modified RNA vaccine that encodes a severe acute …
Drop in ED Visits Related to Child Abuse, Neglect During COVID-19
FRIDAY, Dec. 11, 2020 — During the COVID-19 pandemic, there was a decrease in the total number of emergency department …
Allergic reactions to vaccines rare, short-lived
Vaccines can sometimes cause allergic reactions, but they are usually rare and short-lived. British regulators are looking into reports of …
The worst TikTok health trends of 2020
TikTok has become a library of DIY tips for haircuts, self-care, and health. Not all of the information circulated on …
COVID-19 prevention top concern of home-care agencies, survey finds
Tens of thousands of Massachusetts residents depend on home care to support their health as they age or cope with …
Oxford COVID-19 vaccine is safe and protects against disease, first published results from phase 3 trials
Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases—with …
30% of New Zealanders are ‘vaccine skeptics,’ so trust is key to COVID-19 vaccine roll-out
The emergency approval of the Pfizer/BioNTech COVID-19 vaccine in the UK and the imminent roll-out of several other vaccines in …
Flu Shot More Popular Than COVID-19 Vaccine Among Older Adults
MONDAY, Dec. 7, 2020 — Older adults are less likely to get a COVID-19 vaccine than a flu vaccine, according …
Frontrunners in race for COVID-19 vaccine
Dozens of companies, from biotech start-ups to Big Pharma, are in the race to develop a safe and effective coronavirus …
Pfizer-BioNTech’s Covid-19 vaccine: path ahead in UK
The British government has accepted a recommendation by the country’s independent medicines regulator to approve Pfizer-BioNTech’s COVID-19 vaccine for general …
CDC to shorten COVID-19 quarantine to 10 days, 7 with test
The Centers for Disease Control and Prevention is set to shorten the recommended length of quarantine after exposure to someone …